CBLL1 and neoplasm: Interestingly, using a cohort of 205 samples of CRC patients, including 85 tumour samples with KRAS mutations and 120 tumour samples with KRAS wild type (non-mutated), we detected an association of CBLL1 gene expression with non-mutant KRAS samples, as shown in the boxplot (Supplementary Figure S2d).